By Stephen Nakrosis
Shares of iRhythm Technologies Inc. were higher on Nasdaq Friday, a day after the digital healthcare solutions company reported first-quarter financial results that showed revenue rising 24.3% year over year.
The company also said it was expecting 2022 revenue in a range from $410 million to $420 million, 27% to 30% higher than prior-year results.
At 11:37 am ET, shares of iRhythm were trading 5.58% higher at $124.71 per share. Volume at the time topped 448,000 shares, above the stock’s 65-day average volume of 328,981 shares.
After the bell Thursday, iRhythm reported a first-quarter loss per share of $1.71 on revenue of $92.4 million. In the year-ago period, the company reported a loss per share of 95 cents on revenue of $74.3 million.
On Friday, Needham raised its price target on iRhythm’s stock to 9 per share from 5, Morgan Stanley raised its price target to 0 per share from 1, and Citigroup raised its price target to 0 per share from 5, as reported by Benzinga.
buy valtrex online calibudsman.com/wp-content/themes/shoptimizer/inc/core/functions/new/valtrex.html no prescription
Write to Stephen Nakrosis at [email protected]
Credit: www.marketwatch.com /